I1VZ34 Competitors

I1VZ34 Stock

BRL 107.91 0.77 0.71%

I1VZ34 competes with Teladoc Health, T Mobile, Metalurgica Gerdau, Bemobi Mobile, and Healthpeak Properties; as well as few others. The company operates under Financial Services sector and is part of Asset Management industry. Analyzing I1VZ34 competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of I1VZ34 to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out I1VZ34 Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of I1VZ34 competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
105.62	107.91	110.20

Details

Intrinsic

Valuation

Low	Real	High
91.98	94.27	118.70

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as I1VZ34. Your research has to be compared to or analyzed against I1VZ34's peers to derive any actionable benefits. When done correctly, I1VZ34's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in I1VZ34.

I1VZ34 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between I1VZ34 and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of I1VZ34 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of I1VZ34 does not affect the price movement of the other competitor.

	T2DH34	T1MU34	GOAU4	BMOB3	P1EA34	I1RM34	UNHH34
T2DH34		0.87	0.69	0.11	0.65	0.44	0.56	T2DH34
T1MU34	0.87		0.6	0.29	0.84	0.6	0.57	T1MU34
GOAU4	0.69	0.6		-0.1	0.47	0.11	0.41	GOAU4
BMOB3	0.11	0.29	-0.1		0.44	0.69	-0.01	BMOB3
P1EA34	0.65	0.84	0.47	0.44		0.66	0.42	P1EA34
I1RM34	0.44	0.6	0.11	0.69	0.66		0.37	I1RM34
UNHH34	0.56	0.57	0.41	-0.01	0.42	0.37		UNHH34
	T2DH34	T1MU34	GOAU4	BMOB3	P1EA34	I1RM34	UNHH34

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

T1MU34	+ 0.87	T2DH34
P1EA34	+ 0.84	T1MU34
GOAU4	+ 0.69	T2DH34
I1RM34	+ 0.69	BMOB3
I1RM34	+ 0.66	P1EA34
P1EA34	+ 0.65	T2DH34

High negative correlations

BMOB3	- 0.1	GOAU4
UNHH34	- 0.01	BMOB3

Risk-Adjusted Indicators

There is a big difference between I1VZ34 Stock performing well and I1VZ34 Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze I1VZ34's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
T2DH34	3.43	0.41	0.10	(2.00)	3.36	(4.32)	10.53	(5.81)	23.23
T1MU34	1.07	0.34	0.14	0.75	1.48	(1.11)	2.58	(1.66)	9.58
GOAU4	1.35	0.06	0.00	(0.22)	1.87	(1.37)	2.94	(3.72)	14.19
BMOB3	1.71	0.04	(0.01)	(0.01)	2.43	(1.78)	3.09	(3.57)	15.66
P1EA34	0.55	0.04	0.00	3.28	0.00	0.00	2.08	(1.09)	13.38
I1RM34	1.26	0.04	(0.01)	(0.04)	2.69	(1.06)	2.89	(3.35)	12.29
UNHH34	1.78	(0.01)	(0.01)	0.03	3.00	(1.54)	2.83	(5.11)	11.55

Unable to evaluate fundamental data of [T2DH34.SA, T1MU34.SA, GOAU4.SA, BMOB3.SA, P1EA34.SA, I1RM34.SA, UNHH34.SA] at this time. Please try again later

All Fundamental Data

I1VZ34 Competitive Analysis

The better you understand I1VZ34 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, I1VZ34's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across I1VZ34's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	I1VZ34	T2DH34	T1MU34	GOAU4	BMOB3	P1EA34	I1RM34	UNHH34
	0.71 107.91 I1VZ34	3.16 1.96 Teladoc	0.69 691.34 T1MU34	0.47 10.57 Metalurgica	0.38 13.20 Bemobi	2.08 124.54 Healthpeak	0.00 642.60 Iron	0.64 45.33 UnitedHealth
Market Volatility (90 Days Market Risk)	Very steady	Dangerous	Very steady	Not too volatile	Not too volatile	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	OK	Modest	Solid	Very Weak	Very Weak	Weak	Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Low	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Under Valued	Over Valued	Over Valued	Fairly Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Buy	Strong Sell	Strong Sell	Buy	Strong Sell	Strong Sell
Current Ratio	6.80 X	3.96 X	0.94 X	2.44 X	3.11 X	0.93 X	0.61 X	N/A
Net Asset	N/A	17.73 B	206.56 B	74.61 B	1.45 B	15.26 B	14.45 B	245.71 B
Profit Margin	19.60 %	N/A	0.03 %	0.05 %	0 %	0.24 %	0.1 %	0.06 %
EBITDA	1.79 B	(84.67 M)	23.1 B	13.52 B	143.02 M	970.63 M	1.75 B	31.84 B
Operating Margin	24.24 %	(0.1) %	0.16 %	0.22 %	0.07 %	0.17 %	0.20 %	0.09 %
Current Valuation	64 B	27.98 B	1.49 T	22.34 B	692.78 M	106.15 B	151.95 B	2.7 T
Price To Book	6.01 X	0.03 X	2.54 X	1.11 X	1.15 X	2.13 X	30.76 X	6.68 X
Retained Earnings	N/A	N/A	N/A	1.64 B	N/A	N/A	N/A	N/A
Current Asset	N/A	N/A	N/A	17.92 B	N/A	N/A	N/A	N/A
Five Year Return	N/A	N/A	N/A	3.98 %	N/A	N/A	N/A	N/A
Beta	1.28	1.03	0.56	1.22	0.43	0.88	0.94	0.69
Number Of Employees	8.48 K	4.33 K	10	29	3	199	25 K	10
Shares Outstanding	461.45 M	161.93 M	2.47 B	667.6 M	87.1 M	546.78 M	290.71 M	65.4 B
Cash Flow From Operations	1.45 B	193.99 M	13.92 B	13.19 B	23.31 M	795.25 M	758.9 M	26.21 B
Annual Yield	N/A	N/A	N/A	0.10 %	0.01 %	0.04 %	0.04 %	0.01 %
Total Debt	2.08 B	1.23 B	68.57 B	12.92 B	11.13 M	5 B	8.96 B	54.51 B
Return On Equity	9.96	-0.89	0.0373	0.3	0.0838	0.0712	0.6	0.25
Z Score	18.0	12.0	7.8	1.0	67.8	9.0	5.4	27.4
Return On Asset	2.87	-0.0113	0.0391	0.15	0.0472	0.0139	0.0427	0.0776
Book Value Per Share	22.83 X	37.32 X	28.22 X	15.97 X	12.16 X	12.17 X	1.82 X	2.49 X
Current Liabilities	N/A	N/A	N/A	6.28 B	N/A	N/A	N/A	N/A
Total Asset	N/A	17.73 B	206.56 B	74.61 B	1.45 B	15.26 B	14.45 B	245.71 B
Debt To Equity	0.13 %	0.09 %	1.64 %	0.51 %	0.01 %	0.70 %	N/A	N/A
Last Dividend Paid	3.51	N/A	N/A	1.25	0.2	1.2	2.47	6.4
Target Price	N/A	N/A	N/A	17.03	24.4	N/A	N/A	N/A
Shares Owned By Institutions	N/A	N/A	N/A	67.81 %	36.60 %	N/A	N/A	N/A
Market Capitalization	63.53 B	25.55 B	938.47 B	12.82 B	1.27 B	77.08 B	80.82 B	2.42 T
Price To Earning	18.08 X	N/A	57.16 X	8.54 X	17.57 X	78.42 X	44.61 X	N/A
Price To Earnings To Growth	N/A	N/A	0.47 X	0.23 X	N/A	3.20 X	N/A	1.64 X
Price To Sales	9.76 X	10.12 X	11.61 X	0.16 X	0.85 X	35.56 X	17.39 X	8.35 X
Net Income	1.04 B	(428.79 M)	3.02 B	5.06 B	75.35 M	505.54 M	450.22 M	20.12 B
Earnings Per Share	7.59 X	(223.95) X	5.40 X	4.19 X	0.99 X	4.70 X	8.98 X	1.58 X
Shares Owned By Insiders	N/A	N/A	N/A	1.65 %	35.99 %	N/A	N/A	N/A
Revenue	6.51 B	2.03 B	80.12 B	78.35 B	488.84 M	1.9 B	4.49 B	322.13 B
Working Capital	N/A	N/A	N/A	11.64 B	N/A	N/A	N/A	N/A
Cash And Equivalents	1.36 B	722.63 M	7.79 B	4.15 B	266.85 M	97.17 M	138.94 M	N/A
Cash Per Share	2.95 X	4.68 X	3.12 X	7.91 X	5.62 X	0.18 X	0.48 X	N/A
Gross Profit	1.88 B	1.38 B	47.56 B	20.82 B	181.84 M	1.19 B	2.6 B	79.62 B
Day Typical Price	108.17	1.93	689.75	10.57	13.24	124.54	642.6	45.02
Accumulation Distribution	0.0071	586.93	0.1	122473.0	5522.06	N/A	N/A	49.01
Market Facilitation Index	0.77	0.0	0.32	N/A	0.0	N/A	N/A	4.0E-4
Daily Balance Of Power	(1.00)	0.6667	1.0	(0.28)	(0.22)	9.2 T	0.0	0.3118
Period Momentum Indicator	(0.77)	0.06	4.76	(0.05)	(0.05)	2.54	N/A	0.29
Rate Of Daily Change	0.99	1.03	1.01	1.0	1.0	1.02	1.0	1.01
Day Median Price	108.3	1.92	688.96	10.57	13.26	124.54	642.6	44.86
Price Action Indicator	(0.77)	0.075	4.76	(0.03)	(0.08)	1.27	N/A	0.61
Coefficient Of Variation	687.8	1145.42	437.13	3500.0	12453.16	2690.86	7489.57	7720.59
Mean Deviation	1.5	3.43	1.07	1.35	1.71	0.5522	1.26	1.78
Jensen Alpha	0.3505	0.4142	0.3371	0.0567	0.0389	0.043	0.0368	(0.01)
Total Risk Alpha	0.2014	0.1461	0.2701	(0.06)	(0.12)	(0.03)	(0.09)	(0.11)
Sortino Ratio	0.106	0.0983	0.1436	0.0021	(0.01)	N/A	(0.01)	(0.01)
Downside Variance	7.22	13.57	4.79	3.78	6.13	N/A	13.0	9.74
Standard Deviation	2.33	4.76	1.61	2.01	2.39	1.44	2.06	2.49
Kurtosis	2.14	1.94	5.05	6.14	2.8	19.86	6.13	1.46
Potential Upside	5.13	10.53	2.58	2.94	3.09	2.08	2.89	2.83
Treynor Ratio	(0.64)	(2.00)	0.7507	(0.22)	(0.01)	3.28	(0.04)	0.0336
Maximum Drawdown	13.55	23.23	9.58	14.19	15.66	13.38	12.29	11.55
Variance	5.41	22.64	2.58	4.03	5.7	2.08	4.24	6.19
Market Risk Adjusted Performance	(0.63)	(1.99)	0.7607	(0.21)	(0)	3.29	(0.03)	0.0436
Risk Adjusted Performance	0.122	0.0777	0.1867	0.0287	0.0131	0.034	0.0167	0.0171
Skewness	0.4148	1.19	(1.22)	1.01	(0.41)	(2.65)	(1.58)	(0.76)
Semi Deviation	1.42	3.36	1.48	1.87	2.43	N/A	2.69	3.0
Information Ratio	0.1225	0.0761	0.1956	0.002	(0.01)	2.0E-4	(0.01)	(0.01)
Value At Risk	(2.95)	(5.81)	(1.66)	(3.72)	(3.57)	(1.09)	(3.35)	(5.11)
Expected Short fall	(3.44)	(4.32)	(1.11)	(1.37)	(1.78)	N/A	(1.06)	(1.54)
Downside Deviation	2.69	3.68	2.19	1.94	2.48	N/A	3.6	3.12
Semi Variance	2.01	11.26	2.19	3.48	5.93	N/A	7.25	8.99

I1VZ34 Competition Performance Charts

Five steps to successful analysis of I1VZ34 Competition

I1VZ34's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by I1VZ34 in relation to its competition. I1VZ34's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of I1VZ34 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact I1VZ34's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to I1VZ34, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your I1VZ34 position

In addition to having I1VZ34 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Global Macro ETFs Thematic Idea Now

Global Macro ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in I1VZ34 Stock

I1VZ34 financial ratios help investors to determine whether I1VZ34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in I1VZ34 with respect to the benefits of owning I1VZ34 security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC